Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spectra Optia vs COBE Spectra for MNC Collection in Healthy Donors
NCT02253160Completed
- Sponsor
- Terumo BCT
- Start
- Sep 2014
- Primary completion
- Jan 2015
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Terumo BCT. Primary endpoint: CD34+ Collection Efficiency (CE1). Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT02253160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253160.